Cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the SHR animal model: implications for schizophrenia pharmacotherapy (2016)
- Authors:
- Peres, Fernanda F. - Universidade Federal de São Paulo (UNIFESP)
- Levin, Raquel - Universidade Federal de São Paulo (UNIFESP)
- Almeida, Valéria - Universidade Federal de São Paulo (UNIFESP)
- Zuardi, Antônio Waldo
- Hallak, Jaime Eduardo Cecílio
- Crippa, José Alexandre de Souza
- Abilio, Vanessa C. - Universidade Federal de São Paulo (UNIFESP)
- USP affiliated authors: ZUARDI, ANTONIO WALDO - FMRP ; HALLAK, JAIME EDUARDO CECILIO - FMRP ; CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP
- Unidade: FMRP
- DOI: 10.3389/fphar.2016.00303
- Subjects: CANABINOIDES; MODELOS ANIMAIS; ESQUIZOFRENIA
- Keywords: Prepulse inhibition of startle reflex; Animal models; Schizophrenia; Cannabidiol; Endocannabinoidsystem; SHR strain
- Language: Inglês
- Imprenta:
- Source:
- Título: Frontiers in Pharmacology
- ISSN: 1663-9812
- Volume/Número/Paginação/Ano: v. 7, art. 303, 2016
- Este artigo possui versão em acesso aberto
- URL de acesso aberto
- PDF de acesso aberto
- Versão do Documento: Versão publicada (Published version)
-
Status: Artigo publicado em periódico de acesso aberto (Gold Open Access) -
ABNT
PERES, Fernanda F. et al. Cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the SHR animal model: implications for schizophrenia pharmacotherapy. Frontiers in Pharmacology, v. 7, 2016Tradução . . Disponível em: https://doi.org/10.3389/fphar.2016.00303. Acesso em: 11 mar. 2026. -
APA
Peres, F. F., Levin, R., Almeida, V., Zuardi, A. W., Hallak, J. E. C., Crippa, J. A. de S., & Abilio, V. C. (2016). Cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the SHR animal model: implications for schizophrenia pharmacotherapy. Frontiers in Pharmacology, 7. doi:10.3389/fphar.2016.00303 -
NLM
Peres FF, Levin R, Almeida V, Zuardi AW, Hallak JEC, Crippa JA de S, Abilio VC. Cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the SHR animal model: implications for schizophrenia pharmacotherapy [Internet]. Frontiers in Pharmacology. 2016 ; 7[citado 2026 mar. 11 ] Available from: https://doi.org/10.3389/fphar.2016.00303 -
Vancouver
Peres FF, Levin R, Almeida V, Zuardi AW, Hallak JEC, Crippa JA de S, Abilio VC. Cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the SHR animal model: implications for schizophrenia pharmacotherapy [Internet]. Frontiers in Pharmacology. 2016 ; 7[citado 2026 mar. 11 ] Available from: https://doi.org/10.3389/fphar.2016.00303 - Cannabidiol and neuroprotection: evidence from preclinical studies
- Cannabidiol displays proteomic similarities to antipsychotics in cuprizone-exposed human oligodendrocytic cell line MO3.13
- Marijuana, feijoada and the debate on drug legalization
- Cannabidiol for the treatment of psychosis in Parkinson's disease
- Δ9-THC intoxication by cannabidiol-enriched cannabis extract in two children with refractory epilepsy: full remission after switching to purified cannabidiol
- Administration of harmine and imipramine alters creatine kinase and mitochondrial respiratory chain activities in the rat brain
- Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders
- Cannabidiol administered during peri-adolescence prevents behavioral abnormalities in an animal model of schizophrenia
- Cannabinoid-based therapies and brain development: potential harmful effect of early modulation of the endocannabinoid system
- Cannabidiol reverses memory impairments and activates components of the Akt/GSK3β pathway in an experimental model of estrogen depletion
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
